Novartis
NOVN
Delayed Swiss Exchange - 02/16 05:30:53 pm
80.8CHF
+1.48%
Prev.79.6200
Open80.0000
High80.8000
Low79.4800
Volume3 209 777
Last news
Financials
Sales 2018 52 000 M
EBIT 2018 13 373 M
R. net 2018 8 890 M
Debt 2018 18 067 M
Rend. 2018 3,46%
P/E ratio 2018 21,75
P/E ratio 2019 19,80
EV / Sales 2018 4,76x
EV / Sales 2019 4,55x
Capitalization 229 B
Company
Novartis AG develops, manufactures, and markets healthcare products.It operates through the following segments: Innovative Medicines, Alcon, Sandoz, and Corporate.The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of...
Sector :
Pharmaceuticals - NEC
Calendar :
2018-02-27 Presentation
Trading Rating :
Investor Rating :
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishNeutral
Resistance82,982,987,7
Spread/Res.-2,5%-2,5%-7,9%
Spread/Supp.4,4%4,4%10%
Support77,477,473,3